News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Leuthner Brian A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/18/2019 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Exercised 169,032 restricted stock units
@ $0 |
|
| 12/28/2018 |
4/A
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc. |
| 08/15/2018 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Granted 169,032 restricted stock units
@ $0 |
|
| 06/20/2018 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Granted 338,068 options to buy
@ $1.1, valued at
$371.9k
|
|
| 03/05/2018 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $14.81, valued at
$37k
Sold 2,500 shares
@ $15.08, valued at
$37.7k
Granted 280,000 options to buy
@ $14.98, valued at
$4.2M
|
|
| 02/23/2018 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $15.47, valued at
$38.7k
Sold 2,500 shares
@ $15.37, valued at
$38.4k
|
|
| 02/02/2018 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $13.14, valued at
$32.9k
Sold 2,500 shares
@ $12.96, valued at
$32.4k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2017 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $9.92, valued at
$24.8k
Sold 2,500 shares
@ $9.97, valued at
$24.9k
Sold 2,500 shares
@ $9.68, valued at
$24.2k
|
|
| 11/03/2017 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $10.92, valued at
$27.3k
Sold 2,500 shares
@ $10.94, valued at
$27.4k
Sold 2,500 shares
@ $10.86, valued at
$27.2k
|
|
| 10/04/2017 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $10.81, valued at
$27k
Sold 2,500 shares
@ $10.93, valued at
$27.3k
Sold 2,500 shares
@ $11.14, valued at
$27.9k
|
|
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2016 |
4
| Leuthner Brian A (President and CEO) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 7,500 shares
@ $9.5442, valued at
$71.6k
|
|
| 02/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|